Why a Peptide Can Be 99 Percent Pure and Still Be Entirely the Wrong Molecule

An HPLC purity certificate measures homogeneity, not identity. It answers how much of a sample is one thing, and never which thing. A pure sample of the wrong compound returns a beautiful chromatogram and an excellent percentage.

That distinction decides whether a certificate is worth anything on the compound in front of you. It is why a copper peptide containing no copper passes, why GHK-Cu in the skin and anti-aging peptides category is the clearest case in this market, and why the identity question belongs to mass spectrometry for peptides instead. Reading a real document line by line is covered in how to read peptide lab test results.

What does an HPLC purity percentage actually measure?

HPLC purity measures homogeneity: the percentage of total detected peak area attributable to a single species. High-performance liquid chromatography separates a sample by hydrophobicity on a reversed-phase column and reports what proportion of the signal sits under the main peak. It never establishes which molecule that peak is. A 99.66% average across 736 independent GHK-Cu tests on this platform describes uniformity rather than identity, and the two are not the same measurement.

The mechanics matter only as background. Sample goes onto a column, a solvent gradient pulls compounds off at different rates according to how strongly they stick, a detector records the signal, and software integrates the peaks. The number printed on a certificate is the main peak's area divided by the total area, expressed as a percentage. Nothing in that chain compares the sample against a reference standard unless a laboratory deliberately runs one.

Those two tests are natural rivals only in the sense that buyers substitute one for the other. They answer different questions, and neither substitutes for the other. The rest of this page is about the second column of that table being empty on most certificates.

What can an HPLC purity test not see?

Seven attributes escape HPLC purity entirely, and each has a named case in this market: molecular identity, metal content, stereochemistry, disulfide pairing, salt form, fill quantity and endotoxin. GHK-Cu loses about 62.5 daltons of copper without moving the percentage, FOXO4-DRI's all-D configuration is invisible to an achiral column, and a gonadorelin vial labelled 5 mg tested at 2.12 mg while purity testing stayed silent about the shortfall.

Read that table as a list of separate axes rather than a list of caveats. Purity and quantity fail independently; identity and purity fail independently; sterility is a third discipline again. A vial can be homogeneous, correctly identified, correctly filled and still pyrogenic, which is why endotoxin testing and LAL assay interpretation and peptide sterility testing under USP <71> exist as separate pages.

The three rows carrying the most weight in this market are identity, fill quantity and salt form, because those are the failures with documented examples attached. The next four sections work through the cases.

How does a copper peptide with no copper pass a purity test?

Because HPLC detects no metals, and the copper-free molecule is a legitimate single species. GHK-Cu is a 1:1 copper complex weighing about 403 daltons; the copper-free tripeptide weighs 340.38, a gap of roughly 62.5 Da and about 18% of the molecule. A vial of pure copper-free GHK returns a beautiful purity figure. PubChem compounds the problem by indexing that copper-free peptide, CID 73587, under the synonyms "GHK-Cu," "Copper Peptide" and "Prezatide."

Copper-to-peptide stoichiometry is 1:1 across all copper records, and the full synonym list on the copper-free record runs to six names for a copper complex attached to a molecule containing no copper. An 18% mass difference is enormous by peptide-identity standards and trivially visible on a mass spectrum. It is completely invisible to a test that separates by hydrophobicity and reports peak area.

Peptigrity's own GHK-Cu compound page flags the commercial consequence independently, noting that "some vendors sell free GHK labeled as GHK-Cu (mislabeling) or use suboptimal copper-to-peptide ratios." Elemental analysis measures the metal directly at 1:1 stoichiometry, and we have not seen it offered by any vendor or laboratory serving this market. The full case sits in GHK-Cu: the copper peptide whose purity certificate cannot detect copper, and metals assays generally in peptide heavy metals testing.

What does a purity percentage mean when no analyte is declared?

Considerably less than the same figure means for a defined peptide, and arguably nothing at all. Thymalin's Russian registration names its active substance as "thymus extract," 10 mg per vial, from the thymus glands of calves and cattle under one year of age, with no sequence, no molecular weight and no CAS number declared. HPLC purity is the percentage of peak area attributable to one analyte, and thymalin has no declared analyte to measure against.

Cortexin and Retinalamin sit in the same position. A purity percentage against no declared standard is a category error rather than a weak result, and it is worth naming as one.

A "99% purity" figure on a thymalin certificate is either measuring something that should not be a single peak in a genuine extract, or it is a number produced by an assay never designed for the material. Either way it does not mean what the same number means on a thymosin alpha-1 certificate, where a defined 28-mer of 3,108.3 Da gives mass spectrometry something to confirm. The full argument is in thymalin: what a purity certificate on an undefined extract measures and the science of Khavinson bioregulators.

Why is a perfect peak on PEG-MGF a warning rather than a reassurance?

Because PEGylated products are polydisperse and should not resolve as one clean peak. PEG is a polymer built from repeating ethylene oxide units of 44 daltons each, so a batch contains chains of varying length distributed around a mean and a PEGylated peptide is a family of species rather than a single molecule. Different chain lengths have different retention behaviour. The Purity Index records PEG-MGF at 99.38% across 27 tests with individual results reaching 100.00%.

That top figure deserves scrutiny rather than confidence. A 100.00% HPLC result is more consistent with a non-PEGylated peptide, or with an assay not designed for this material, than with a well-made PEGylated product. Polydispersity is not a defect in the technique — approved PEGylated biologics handle it by specifying the distribution rather than a single mass — and nothing in this market specifies a distribution.

The degree of PEGylation is the attribute that defines the product, and it is the attribute nobody measures. Whether the material is PEGylated once, multiple times, at the intended site, or not at all requires specialised methods we have not seen offered by any vendor or third-party laboratory serving this market. Full detail sits in PEG-MGF: a muscle growth factor with no defined molecular weight.

Which storage failures survive an HPLC purity test?

Most of them. HPLC measures homogeneity, so a vial in which every molecule has degraded the same way still returns one clean peak and an excellent percentage. Four compounds in this fact base carry a named, structure-specific degradation route that behaves exactly like that: MOTS-c and VIP oxidise at methionine for +16 Da per site, oxytocin's Cys1–Cys6 disulfide reduces for +2 Da, and glutathione oxidises into GSSG, a separate compound with its own PubChem record.

A reduced oxytocin — bridge broken, chain linear — differs from the intact peptide by two hydrogen atoms and will happily return a high HPLC purity figure while being pharmacologically inert. That is the cleanest single demonstration that area percent is not a potency measurement. Handling detail is in why a badly stored peptide still passes an HPLC purity test.

Why can an HPLC column not see a D-amino acid?

Because D and L residues are chemically identical to an achiral column. They share identical molecular formulas, identical molecular weights and identical monoisotopic masses, they co-elute on the reversed-phase columns used for purity testing, and they produce identical mass spectra. FOXO4-DRI is a 46-residue all-D-amino-acid peptide at roughly 5,358 Da; a vial synthesised from ordinary L-amino acids would match every specification on a certificate and be degraded by serum proteases within minutes.

SS-31 shows the same gap and its instructive opposite in one molecule. The tetrapeptide D-Arg-Dmt-Lys-Phe-NH₂ has a free-base weight of 639.79, and mass spectrometry rules out tyrosine substituting for 2,6-dimethyltyrosine because that substitution is a clean −28 Da shift. The D-arginine is invisible to the same instrument, because D-Arg and L-Arg are isobaric. One possible substitution is trivially caught; the other is invisible to everything a vendor routinely performs.

Chiral chromatography or amino acid analysis with chiral derivatisation reaches the question, and we have not seen either offered by any vendor or third-party laboratory serving this market. The Purity Index records FOXO4-DRI at 99.55 across 47 recency-weighted tests from 11 laboratories (verified August 2026), against a platform composite of 99.50 — a number that cannot establish the only property separating the compound from a cheaper, pharmacologically inert L-peptide of identical mass. See FOXO4-DRI science and SS-31 and elamipretide.

Which claims about HPLC purity survive scrutiny?

Two of eight. HPLC genuinely measures homogeneity and genuinely detects synthesis-related impurities that share neither retention nor identity with the target — those hold. Everything else fails: purity does not confirm identity, does not detect copper, does not resolve one-dalton pairs, does not report quantity, does not see stereochemistry, and does not establish that a stored vial still contains the intact molecule.

The second row carries a real caveat rather than an endorsement. HPLC does useful work on deletion sequences, truncations and process residues that differ enough in hydrophobicity to separate, which is why the test is standard. The failures listed below it are all cases where the impurity is not an impurity at all — it is a different, perfectly homogeneous molecule.

What do 11,852 independent HPLC tests establish, and what do they not?

They establish homogeneity at scale and nothing about identity. Peptigrity tracks 530 shops, 11,852 independent lab tests, 118 peptides and 1,283 community reviews (verified August 2026), with a platform composite purity of 99.50 and trust scores weighted 50% community reviews and 50% independently verified lab purity. GHK-Cu holds the deepest dataset here at 99.66% across 736 independent HPLC tests across 230 verified vendors (verified May 2026). None of those 736 tests measures copper.

That sentence is the honest limit of our own largest asset, and it applies compound by compound rather than in general. Oxytocin sits at 98.96 across 53 recency-weighted tests from 14 laboratories (verified August 2026), the lowest score of any well-tested compound we track and one of the smallest denominators — a composite of 98.96 most plausibly represents oxidation products, disulfide scrambling or deamidation for a bridged peptide, which is an inference from structure rather than a measurement of cause.

GHK-Cu price data shows 59 shops in stock, a median of $0.70/mg and a lowest tracked price of $0.12/mg on a 100 mg vial (verified 8 August 2026). Those figures exclude shipping, taxes and customs, coupon codes, bulk tiers, multi-vial kits and account-gated pricing. Compare within a single vial-size band, because fixed per-vial costs push the per-milligram figure down as fill size rises. Individual results are searchable in the lab test database, the weighting is documented in how we calculate trust scores, and the underlying benchmark question is handled in peptide purity standards.

How should you read an HPLC result on your own certificate?

Read it as one axis of four, and read the fields around it before the percentage. A purity figure is informative when the compound has a defined analyte, when a mass result sits beside it, when the salt form is stated and when the batch matches your vial. It is uninformative or actively misleading when any of those is missing, and it is a category error on an undefined extract regardless of how high it goes.

Two rows are worth singling out. Salt form is cheap to check and moves real mass: MOTS-c ships at 2,174.6 free base, 2,234.64 acetate and 2,288.6 TFA salt, so a vial labelled 10 mg of TFA salt contains roughly 9.5 mg of peptide, as TFA versus acetate versus amidate salt forms sets out. And quantitative content is a different assay from purity, which is the entire argument of why 10 mg isn't 10 mg. Document-level patterns are catalogued in red flags in peptide certificates of analysis.

The trial that would settle what a purity certificate is worth

No published study has submitted known, deliberately mis-specified peptide samples to the laboratories serving this market and reported what came back. That is the experiment the whole argument rests on, and it does not exist. Everything above is inference from analytical chemistry plus a catalogue of documented anomalies in our own dataset, which is weaker than a blinded round-robin would be, and we would rather say so than imply otherwise.

Where the purity number stops

An HPLC purity result answers one narrow question well and is routinely asked to answer four others it cannot reach. The percentage tells you the tested material was homogeneous; identity, quantity, stereochemistry and pyrogen load are separate measurements that fail independently of it, and each has a documented failure in this market with a compound name attached. A certificate carrying only a purity figure has addressed roughly a quarter of the problem.

The practical consequence is a reading order rather than a rejection. Establish that the compound has a declared analyte, ask for a batch-matched mass result, read the salt form, read the quantitative content, then read the percentage — and on GHK-Cu, an undefined extract or a PEGylated product, weight the percentage close to zero.

Browse the skin and anti-aging peptides category, or our complete peptide guide with 118 compounds (verified August 2026). For per-injection volume, use the GHK-Cu calculator alongside the reconstitution calculator. Compare shops through independent lab tests and community-verified shop reviews, and see how to verify peptide quality before you buy for the full sequence.

Frequently Asked Questions

Does a 99% HPLC result mean I received the right peptide?

No. It means 99% of the detected peak area was a single species. Which species is a separate question that HPLC does not address, and the corpus carries cases where the answer was wrong: copper-free GHK sold as GHK-Cu, melanotan II a single dalton from PT-141, and an L-peptide indistinguishable from an all-D one. Ask for a batch-matched mass spectrometry result.

Why does HPLC not detect the copper in GHK-Cu?

Because chromatography separates by hydrophobicity and detects no metals. The copper complex weighs about 403 daltons and the copper-free tripeptide 340.38, a gap of roughly 62.5 Da or 18% of the molecule, and a pure sample of the copper-free peptide returns an excellent purity figure. Mass spectrometry separates them instantly; elemental analysis measures the metal directly and is not offered in this market.

Can HPLC tell whether a peptide has degraded in storage?

Usually not. A vial in which every molecule has oxidised the same way still gives one clean peak. Methionine oxidation adds 16 daltons on MOTS-c and VIP, a reduced oxytocin disulfide adds 2 daltons, and glutathione oxidises into GSSG entirely. All four pass purity testing and all four are visible to mass spectrometry.

Is a 100% purity result a good sign?

Not always. On PEG-MGF it is a warning, because PEG is polydisperse and genuinely PEGylated material carries a chain-length distribution rather than a single clean peak. One vendor sample returned 100.00% against a compound average of 99.38% across 27 tests, which is more consistent with a non-PEGylated peptide or an unsuitable assay than with a well-made product.

What does a purity percentage mean on thymalin or Cortexin?

Very little. Those products are undefined animal-tissue extracts with no declared sequence, molecular weight or CAS number, so there is no analyte for a percentage to be a percentage of. For that class, endotoxin and sterility testing carry more weight than purity, because pyrogen contamination is the realistic failure mode for injectable material derived from animal tissue.

If purity does not prove identity, what should I ask a vendor for?

A batch-matched certificate carrying mass spectrometry, the salt form, a quantitative content result in milligrams, and an LAL endotoxin figure, from a named third-party laboratory. Purity belongs on that list, not at the top of it. On compounds where stereochemistry or metal content is the defining attribute, expect to be told the assay is unavailable — the answer itself is informative.

This article is for educational and informational purposes only and does not constitute medical advice. Peptides discussed may be investigational compounds not approved by the FDA (or equivalent regulators in your jurisdiction) for human use. Always consult a qualified healthcare provider before using any peptide or research compound. Peptigrity is an independent review platform and does not sell, endorse, or recommend specific products or vendors.